Novel 2-(2-Thienyl)-thiazolo[4,5- d ]pyrimidin-7(6 H )-ones Binding β+/α– Subunit Interface as GABA A R Positive Allosteric Modulator for the Treatment of Status Epilepticus in Mouse
Journal of Medicinal Chemistry · 2025
DOI: 10.1021/acs.jmedchem.5c00903 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Weiming Liao und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China. Hauptthemen laut MEDLINE: Status Epilepticus, Receptors, GABA-A, Anticonvulsants, Thiazoles. Die Arbeit nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Status epilepticus (SE), a life-threatening neurological emergency, is primarily treated with benzodiazepines (BZDs), which act as positive allosteric modulators (PAMs) of γ2-containing GABAA receptors (GABAARs). However, their efficacy diminishes due to γ2 subunit internalization, leading to pharmaco-resistance. In this manuscript, a series of 2-(2-thienyl)-thiazolo[4,5-d]pyrimidin-7(6H)-one derivatives were designed and evaluated using two-electrode voltage clamp in Xenopus oocytes expressing α1β2 GABAARs. We identified (S)-9d as a potent α1β2γ2 subtype PAM, showing 13-fold potentiation at 10 μM (EC50: 0.9 μM in oocytes, 0.2 μM in CHO cells) as well as α1β2 (EC50 = 1.3 μM, 1700% enhancement, in oocytes). Molecular docking and mutagenesis revealed (S)-9d binds to a distinct β+/α- interface of α1β2 GABAARs. In SE mouse models, (S)-9d (5-30 mg/kg) significantly suppressed seizure progression and reduced delayed mortality, outperforming diazepam. This study establishes a promising strategy for refractory SE to overcome BZD limitations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
- Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
ORCID-Profile: Liangren Zhang, Qi Sun, Zhuo Huang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liao, W., Wang, Z., Wang, H., Zheng, Y., Wang, J., Li, Y., Wang, W., Wang, X., Zhang, L., Sun, Q., & Huang, Z. (2025). Novel 2-(2-Thienyl)-thiazolo[4,5- d ]pyrimidin-7(6 H )-ones Binding β+/α– Subunit Interface as GABA A R Positive Allosteric Modulator for the Treatment of Status Epilepticus in Mouse. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c00903
Vancouver
Liao W, Wang Z, Wang H, Zheng Y, Wang J, Li Y, et al. Novel 2-(2-Thienyl)-thiazolo[4,5- d ]pyrimidin-7(6 H )-ones Binding β+/α– Subunit Interface as GABA A R Positive Allosteric Modulator for the Treatment of Status Epilepticus in Mouse. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.5c00903
BibTeX
@article{Liao2025,
author = {Liao, Weiming and Wang, Zihan and Wang, Han and Zheng, Yulin and Wang, Jie and Li, Yunzhe and Wang, Wei and Wang, Xiaowei and Zhang, Liangren and Sun, Qi and Huang, Zhuo},
title = {Novel 2-(2-Thienyl)-thiazolo[4,5- d ]pyrimidin-7(6 H )-ones Binding β+/α– Subunit Interface as GABA A R Positive Allosteric Modulator for the Treatment of Status Epilepticus in Mouse},
journal = {Journal of Medicinal Chemistry},
year = {2025},
doi = {10.1021/acs.jmedchem.5c00903}
}
EUVIMED